These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 90138)

  • 1. Urinary glycosaminoglycans in patients with progressive myoclonus epilepsy.
    Federico A; D'Auria N
    J Neurol; 1979 Jan; 220(4):291-5. PubMed ID: 90138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content and composition of urinary glycosaminoglycans in the patients with myoclonus epilepsy with and without Lafora bodies.
    Constantopoulos G; Dekaban AS; Steusing JK; Eldridge R
    Acta Neurol Scand; 1977 Oct; 56(4):291-8. PubMed ID: 200053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of indican in progressive myoclonus epilepsy without Lafora bodies. The effect of sodium valproate.
    Koskiniemi M; Palo J
    J Neurol Sci; 1978 Dec; 39(2-3):235-9. PubMed ID: 105091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial progressive myoclonic epilepsy. A clinical, genetical, biochemical and patho-anatomical study of a family with a 6-year follow-up.
    Pedersen E; Grynderup V; Kissmeyer-Nielsen F; Nielsen J; Poulsen JH; Reske-Nielsen E
    J Neurol Sci; 1982 Feb; 53(2):305-20. PubMed ID: 6276514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of myoclonic seizures.
    Striano P; Belcastro V
    Expert Rev Neurother; 2012 Dec; 12(12):1411-7; quiz 1418. PubMed ID: 23237348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of phenytoin for treatment of late stage progressive myoclonus epilepsy complicated with status epilepticus.
    Miyahara A; Saito Y; Sugai K; Nakagawa E; Sakuma H; Komaki H; Sasaki M
    Epilepsy Res; 2009 Apr; 84(2-3):201-9. PubMed ID: 19268538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excretion patterns of urinary glucosaminoglycans in a family with progressive familial myoclonus epilepsy.
    Poulsen JH
    Acta Neurol Scand; 1975 Sep; 52(3):216-30. PubMed ID: 125520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H
    Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myoclonus and epilepsies in children].
    Fejerman N
    Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of progressive myoclonus epilepsy with TRH.
    Tanaka C; Maegaki Y; Koeda T; Ohta S; Takeshita K
    Pediatr Neurol; 1998 May; 18(5):442-4. PubMed ID: 9650689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiogical and neuropharmacological studies in a patient with progressive myoclonus-epilepsy (author's transl)].
    Rumpl E; Gerstenbrand F; Hengl W; Binder H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1977 Jun; 8(2):77-81. PubMed ID: 408123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug.
    Pranzatelli MR; Tate ED
    Pediatr Neurol; 2001 Nov; 25(5):385-9. PubMed ID: 11744313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine.
    Hurd RW; Wilder BJ; Helveston WR; Uthman BM
    Neurology; 1996 Nov; 47(5):1264-8. PubMed ID: 8909441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonic occipital photosensitive epilepsy with dystonia (MOPED): A familial epilepsy syndrome.
    Sadleir LG; Paterson S; Smith KR; Redshaw N; Ranta A; Kalnins R; Berkovic SF; Bahlo M; Hildebrand MS; Scheffer IE
    Epilepsy Res; 2015 Aug; 114():98-105. PubMed ID: 26088892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases.
    Häusler M; Kluger G; Nikanorova M
    Neuropediatrics; 2011 Feb; 42(1):28-9. PubMed ID: 21557146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neuropsychological considerations in a case of unrecognized myoclonic epileptic jerks dramatically controlled by levetiracetam.
    Gentile V; Brunetto D; Leo I; Bonetti S; Verrotti A; Franzoni E
    Neuropediatrics; 2010 Dec; 41(6):270-2. PubMed ID: 21445819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies.
    Mervaala E; Andermann F; Quesney LF; Krelina M
    Neurology; 1990 Jan; 40(1):53-6. PubMed ID: 2104965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating myoclonic epilepsy in children: state-of-the-art.
    Striano P; Belcastro V
    Expert Opin Pharmacother; 2013 Jul; 14(10):1355-61. PubMed ID: 23668690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.